Literature DB >> 2478301

The mechanism of action of the immunosuppressive drug FK-506.

J E Kay1, S E Doe, C R Benzie.   

Abstract

The novel immunosuppressive drug FK-506 inhibits the induction of lymphocyte proliferation in vitro by mitogenic combinations of phorbol esters and calcium ionophores. Early events inducible by phorbol esters alone are unaffected, while changes induced by calcium ionophores alone are completely suppressed by as little as 0.1 nM FK-506. The event in lymphocyte activation inhibited by FK-506 is completed early in the response. Its completion requires the provision of a Ca2+ signal and concurrent activation of protein kinase C and is accelerated as a function of the strength of protein kinase C activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478301     DOI: 10.1016/0008-8749(89)90121-4

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Mechanisms of dendritic spine remodeling in a rat model of traumatic brain injury.

Authors:  John N Campbell; Brian Low; Jonathan E Kurz; Sagar S Patel; Matt T Young; Severn B Churn
Journal:  J Neurotrauma       Date:  2011-09-29       Impact factor: 5.269

2.  Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin.

Authors:  C P Connern; A P Halestrap
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.

Authors:  P S Randhawa; R Shapiro; M L Jordan; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1993-01       Impact factor: 6.394

4.  Inhibition of T and B lymphocyte proliferation by rapamycin.

Authors:  J E Kay; L Kromwel; S E Doe; M Denyer
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

5.  FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae.

Authors:  J Heitman; N R Movva; P C Hiestand; M N Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

6.  Regional calcineurin subunit B isoform expression in rat hippocampus following a traumatic brain injury.

Authors:  James W Bales; Xiecheng Ma; Hong Q Yan; Larry W Jenkins; C Edward Dixon
Journal:  Brain Res       Date:  2010-08-13       Impact factor: 3.252

7.  The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).

Authors:  C Bolton
Journal:  Agents Actions       Date:  1992-01

Review 8.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Variation in PPP3CC Genotype Is Associated with Long-Term Recovery after Severe Brain Injury.

Authors:  Nicole D Osier; James W Bales; Bunny Pugh; Samuel Shin; Julie Wyrobek; Ava M Puccio; David O Okonkwo; Dianxu Ren; Sheila Alexander; Yvette P Conley; C Edward Dixon
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

Review 10.  A Review of Calcineurin Biophysics with Implications for Cardiac Physiology.

Authors:  Ryan B Williams; Christopher N Johnson
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.